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The origin recognition complex (ORC) is an initiator
protein for DNA replication, but also effects transcrip-
tional silencing in Saccharomyces cerevisiae and hetero-
chromatin function in Drosophila. It is not known, how-
ever, whether any of these functions of ORC is
conserved in mammals. We report the identification of a
novel protein, HBO1 (histone acetyltransferase binding
to ORC), that interacts with human ORC1 protein, the
largest subunit of ORC. HBO1 exists as part of a multi-
subunit complex that possesses histone H3 and H4
acetyltransferase activities. A fraction of the relatively
abundant HBO1 protein associates with ORC1 in human
cell extracts. HBO1 is a member of the MYST domain
family that includes S. cerevisiae Sas2p, a protein in-
volved in control of transcriptional silencing that also
has been genetically linked to ORC function. Thus the
interaction between ORC and a MYST domain acetyl-
transferase is widely conserved. We suggest roles for
ORC-mediated acetylation of chromatin in control of
both DNA replication and gene expression.
The origin recognition complex (ORC)1 is a key protein for
the initiation of DNA replication in eukaryotes. Initially iden-
tified in Saccharomyces cerevisiae (1), ORC is a multisubunit
protein composed of six polypeptides that binds to yeast repli-
cation origins in vivo and in vitro and is essential for the
initiation of DNA replication (2). Homologues of S. cerevisiae
ORC subunits have been identified in Schizosaccharomyces
pombe, Drosophila melanogaster, Arabidopsis thaliana, Xeno-
pus laevis, and human cells (3–14). Xenopus ORC is necessary
for chromosome replication in egg extracts (7, 8, 15–18). More-
over, Drosophila ORC2 is required for chromosome replication
in diploid cells and chorion gene amplification in anuploid
ovarian follicle cells (6, 19). These observations suggest an
evolutionary conserved role for ORC in DNA replication.
In addition to its role in initiation of DNA replication in S.
cerevisiae, ORC has separable functions in S and M phase (20)
and an interesting function in transcriptional silencing of the
mating type loci (21–27). ORC binds to specific, cis-acting si-
lencer elements that are adjacent to the HMRa and HMLa
silent mating-type genes (21–24, 28). To facilitate this function,
the budding yeast silencing protein Sir1p has been shown to
associate with ORC via an interaction with Orc1p (29, 30).
Sir1p has been proposed to stabilize a heterochromatin-like
protein complex containing ORC, Rap1p, Sir2p, Sir3p, and
Sir4p, which represses gene expression in a heritable manner
(31).
In Drosophila, transcriptional silencing and position effect
variegation of gene expression occurs when chromosomal rear-
rangements bring genes in close proximity to heterochromatin
(32). This silencing requires the participation of a structural
component of heterochromatin known as HP1 (33). Interest-
ingly, Drosophila ORC (dORC) binds to HP1, and heterozy-
gous, recessive lethal mutations in ORC2 cause a suppression
of position effect variegation and disrupted localization of HP1
(34, 35). These findings suggest that ORC plays a role in
recruitment of silencing factors to specific chromosomal loci in
both yeast and Drosophila. It has not been determined, how-
ever, whether ORC has a similar function in mammalian cells.
During a search for factors that bind to human ORC protein
subunits, we uncovered a novel protein that interacts with the
largest subunit of human ORC, ORC1. A full-length cDNA
encoding the novel protein was cloned, revealing sequence sim-
ilarities to a subfamily of recently identified histone acetyl-
transferases that contain the MYST domain, including the S.
cerevisiae Sas2p. The protein encoded by this cDNA was
termed Histone acetyltransferase Bound to ORC 1 (HBO1).
Biochemical studies show that a fraction of the HBO1 protein
binds to ORC1 in vivo and that HBO1 is in a large protein
complex that contains histone acetyltransferase activity. The
biochemical interaction between human ORC1 and HBO1 pro-
teins suggest similarities to the genetic interactions between S.
cerevisiae Orc1p and a putative histone acetyltransferase
called Sas2p, a protein involved in transcriptional silencing in
yeast.
EXPERIMENTAL PROCEDURES
Identification of a cDNA Encoding a Human ORC1 Protein-binding
Protein—Human full-length ORC1 cDNA from pKG28 (11) was cloned
into the SmaI and BamHI sites of the pBTM116 vector (a gift from
Linda van Aelst, Cold Spring Harbor Laboratory), carrying the TRP1
gene and a lexA DNA-binding domain, to generate plexAhORC1. Yeast
strain L40 (36, 37) (MAT a his3D200 trp1–901 leu2–3, 112 ade2 lys2–
801am URA3::(lexAop)8-lacZ LYS2::(lexAop)8-HIS3) harboring the pl-
exAhORC1 plasmid was transformed with a cDNA library cloned in the
pGADGH vector (a gift from Linda van Aelst), carrying the LEU2 gene
and the GAL4 activation domain. 3 3 106 transformants were screened
initially by histidine nutritional selection and 975 His1 colonies were
assayed for b-galactosidase activity, resulting in 314 His1b-gal1 clones.
171 Trp2 Leu1 clones, which lost b-galactosidase activity after curing of
the bait plasmid plexAhORC1 were selected. Restoration of b-galacto-
sidase activity was assayed to test the specificity of interaction after
adding back the plasmid plexAhORC1 or plexAHRAS by mating with
AMR70 (MATa his3D200 lys2–801am trp1–901 leu2–3 112 URA::
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(lexAop)8-lacZ) (38) harboring that plasmid. cDNA clones encoding
putative ORC1-interacting proteins were rescued from yeast, trans-
formed into Escherichia coli DH5a, isolated, and sequenced on both
strands with the use of an ABI 377 sequencer. The 59 region of the
HBO1 cDNA was cloned (pL74w1) by hemi-nested polymerase chain
reaction with a lgt10 vector primer (59-CTTATGAGTATTTCTTC-
CAGGGTA-39) and gene-specific primers (59-CACCAGGTGGGTGTT-
TCCACACAC-39, 59-CACCTTGCATTCGTCAGCTGAGAA-39, and 59-
CGCGTCGACCTGCCTGAGTCCTTCAGGGA-39) using as template
DNA, a cDNA library from the human teratocarcinoma cell line
NTera2D1 (39). The nucleotide sequence of the cloned polymerase chain
reaction product was verified by comparison to that determined by
direct sequencing. A full-length cDNA clone was constructed (plasmid
pBSSKL74). The GenBankTM accession number is AF074606. A com-
parison of the human cDNA against the National Center for Biotech-
nology Information (NCBI) data bases was done with the basic local
alignment search tool (BLAST) algorithm (40).
The open reading frame encoding the HBO1 protein was fused at its
59 end to the open reading frame encoding glutathione S-transferase
(GST) in the vector pET11cGST (a gift from Masumi Hidaka, National
Institute of Basic Biology, Japan) to create plasmid pGSTL74. The
recombinant protein was expressed in E. coli and purified by column
chromatography on glutathionine-Sepharose-4B as described by the
manufacturer (Amersham Pharmacia Biotech).
RNA Expression—Multiple tissue Northern blots (CLONTECH)
were probed using the Express Hybridization solution (CLONTECH)
with a 32P-labeled cDNA probe (pL74w1) prepared using the Prime-It
random primer labeling kit (Stratagene) and a Microspin S-400 HR
Column (Amersham Pharmacia Biotech) to remove unincorporated
[a-32P]dCTP.
Antibodies and Immunological Methods—Peptides CSH429 (H-MA-
HYPTRLKTRKTY-NH2) derived from the human ORC1 peptide se-
quence (11) and L74-1 (H-SLKDSGSDLSHRPKR-NH2) derived from
the HBO1 peptide sequence (Fig. 1A) were synthesized (Research Ge-
netics), conjugated to keyhole limpet hemocyanin using m-maleimido-
benzoyl-N-hydroxysulfosuccinimide ester (Pierce) and injected into rab-
bits to generate polyclonal anti-peptide antisera (named CS171 for
hORC1, and CS445 and CS446 for HBO1). Antibodies were affinity
purified as described (41) using a peptide affinity column prepared by
cross-linking the peptide to Sulfo Link resin (Pierce). The hORC1 and
HBO1 cDNAs were cloned into the BamHI and XbaI sites of the NCITE
vector (a gift from William Tansey and Winship Herr, Cold Spring
Harbor Laboratory), a derivative of the pCITE-2a(1) vector (Novagen)
with a hemagglutinin epitope tag to create the plasmid pNCITEL74. In
vitro translation was performed using the TNT system (Promega) and
the products were diluted 25-fold in buffer H/0.05 (20 mM HEPES-
NaOH (pH 7.5), 1 mM EDTA, 1 mM EGTA, 5 mM magnesium acetate,
10% glycerol, 0.01% Nonidet P-40; containing 50 mM NaCl) and incu-
bated at 4 °C for 2 h before immunoprecipitation with rabbit anti-
hORC1 (CS171) or rabbit anti-HBO1 (CS446) crude serum and protein
A-Sepharose beads. Following extensive washes in buffer H/0.05, im-
munoprecipitated proteins were detected by SDS-polyacrylamide gel
electrophoresis and fluorography.
293 cell nuclear extract (42) was immunoprecipitated in buffer H/0.2
with anti-hORC1 antibodies (CS171) cross-linked to protein A-Sepha-
rose beads (Amersham Pharmacia Biotech). After extensive washes
with buffer H/0.2, immunoprecipitated proteins were eluted and ana-
lyzed by Western blotting and probed with anti-HBO1 (CS445) antibod-
ies. For transient expression of human ORC1 tagged with the phage T7
epitope (T7-hORC1), 293 cells were electroporated with 10 mg of pKG28
(11), and cell extracts were prepared as described previously (11). The
soluble lysate was subjected to immunoprecipitation with affinity pu-
rified antibodies against HBO1 protein cross-linked to protein A-Sepha-
rose beads (Amersham Pharmacia Biotech). The immune complexes
were separated by SDS-polyacrylamide gel electrophoresis and immu-
noblotted with a mouse monoclonal antibody against the T7 epitope
(Novagen).
Mapping the Interaction Site within Human ORC1—plexAhORC1cas
was constructed by inserting the cassette 59-BamHI-CTACCGCGGTA-
ACTGACTGG-SalI-39, at the 39 end of the coding sequence of plex-
AhORC1, to ensure efficient termination of translation. Plasmids plex-
AhORC1 (1–621) and plexAhORC1 (1–208) were generated by digestion
of plexAhORC1cas with SacI plus BamHI and MscI plus BamHI, re-
spectively, followed by end filling with the Klenow enzyme, gel purifi-
cation of the larger DNA fragment, and self-ligation. A 6-kilobase pair
DNA fragment released by EcoRI digestion of plexAhORC1cas was gel
purified and self-circularized to produce plexAhORC1 (510–861). A
0.6-kilobase pair EcoRI-BglII fragment of plexAhORC1cas was ligated
to the 5-kilobase pair EcoRI-BamHI fragment of plexAhORC1cas to
generate plexAhORC1 (1–278). A 2-kilobase pair fragment derived from
MscI digestion and Klenow treatment followed by BamHI digestion of
plexAhORC1cas was inserted into the SmaI and BamHI sites of the
pBTM116 vector to generate plexAhORC1 (210–861). In-frame fusion
of lexA and hORC1 in the plexAhORC1 (210–861) construct was con-
firmed by sequencing. A DNA fragment encoding hORC1 (488–750) was
amplified from plexAhORC1 (488–750) by polymerase chain reaction
using primers 59-CCGGGATCCTGGAGGAAGCCCGACTGA-39 and 59-
CGCGTCGACTTAGTGGGCTATGGTGACCAGGC-39 and Pfu DNA po-
lymerase (Stratagene), cut with SalI and BamHI, and cloned into the
SalI and BamHI sites of pBTM116 to generate plexAhORC1 (488–750),
whose sequence was verified by DNA sequencing.
Nucleosome Reconstitution—Nuclear histones were reconstituted us-
ing recombinant Xenopus H32zH42 tetramers (8 mg) (a gift from Drs. K.
Luger and T. Richmond, Eidgeno¨ssische Technische Hochschule, Zu¨r-
ich) and a plasmid pEGFP-C3 (CLONTECH) (15 mg) by salt gradient
dialysis (43).
Detection of Histone Acetyltransferase Activity—The HBO1 polypep-
tide was immunoprecipitated with anti-HBO1 serum from a 293 nu-
clear extract (42) in buffer H/0.2. Histone acetyltransferase (HAT) ac-
tivity was determined with a mixture of recombinant Xenopus histone
H32zH42 tetramers (100 mg/ml) (a gift from Drs. K. Luger and T. Rich-
mond) (44), human histone H2AzH2B purified from HeLa cells (100
mg/ml) (a gift from Dr. A. Verreault) (45), and 23 pmol of [3H]acetyl
coenzyme A (11.2 Ci/mmol, Andotek) in 12.5 ml of HAT buffer (25 mM
Tris-HCl, pH 8.5, 1 mM dithiothreitol, 0.5 mM EDTA, 5 mM sodium
butyrate, 150 mM NaCl, 10% glycerol) and incubated at 37 °C for 1 h.
The histones were resolved in a SDS-18% polyacrylamide gel (46), and
visualized by Coomassie Brilliant Blue staining and fluorography. The
human HAT1 holoenzyme (a gift from Dr. A. Verreault) was used as a
positive control in HAT assays. For quantitative liquid assays, HAT
activity was measured after incubation at 37 °C for 30 min using a
phosphocellulose filter-binding assay, as described previously (47).
Affinity Purification of HBO1 Protein—HBO1 was immunoprecipi-
tated from a 293 cell nuclear extract (42) in buffer H/0.4 with affinity
purified anti-HBO antibodies (CS446) cross-linked to protein A-Sepha-
rose beads. After extensive washing with buffer H/0.4, the beads were
incubated at 4 °C for 30 min. in buffer H/0.4 containing 2 mg/ml of the
L74–1 peptide to elute the immune complex.
A 293 cell nuclear extract was dialyzed against buffer H/0.1 and
loaded onto a 0.25-ml POROS 20 HQ anion exchange column (Roche
Molecular Biochemicals). The column was eluted at 0.2 ml/min with a
linear salt gradient (2.5-ml gradient) from 100 to 1,000 mM NaCl in
buffer H.
RESULTS AND DISCUSSION
To gain insight into human ORC function, we screened a
HeLa cell cDNA library by the two-hybrid method using human
ORC1 protein (hORC1) as bait, and obtained eight independent
cDNA clones whose interaction with hORC1 was specific. The
characterization of one clone, L74, is described here. The cDNA
sequence encodes a 611-amino acid protein with a predicted
molecular mass of 83 kDa (Fig. 1A). No in-frame stop codon was
found upstream of the first methionine, however, this methio-
nine is likely to be the initiation codon, because the size of the
protein translated from this cDNA is the same as that of the
protein present in human cells (data not shown).
Based upon our finding that the L74 cDNA encodes a protein
that binds to hORC1 and is a subunit of a histone acetyltrans-
ferase (see below), we termed the protein HBO1, an acronym
for Histone acetyltransferase Binding to hORC1. Two sequence
motifs were noted (Fig. 1B). One was a serine-rich region lo-
cated at the amino terminus of the protein. The other feature,
revealed by a BLASTP search of the nonredundant protein
data base, is a 270-amino acid carboxyl-terminal region known
as a MYST domain (48–52). This motif contains a putative
acetyl-coenzyme A (acetyl-CoA) binding domain (53) (Fig. 1C).
Throughout the MYST domain, HBO1 is approximately 50%
identical and 70% similar to several other MYST domain pro-
teins (Fig. 1B), many of which have been implicated in tran-
scriptional regulation. One particular protein of interest,
Sas2p, promotes silencing of the silent mating type gene at
ORC Interacting Protein23028
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FIG. 1. Amino acid sequence of HBO1, comparison with other MYST domain proteins, and mRNA expression in human tissues. A,
amino acid sequence of HBO1 deduced from the cDNA clone. The underlined peptide sequence was used as an antigen to generate a rabbit
polyclonal antiserum against HBO1. B, diagram showing the relationship between HBO1 and other MYST domain proteins. The MYST domain
itself is represented as a gray box, and the putative acetyl-CoA-binding domain is shown as a black box. The serine-rich domain is depicted as SER.
The MYST domain proteins are listed in decreasing order of similarity with HBO1 within the MYST domain. Abbreviations are as follows: Moz,
monocytic leukemia zinc finger protein (51); Tip60, Tat interactive protein, 60 kDa (16); SAS, something about silencing (48, 49); ESA, essential
SAS-related acetyltransferase (54); mof, males-absent on the first (50); hs, Homo sapiens; sc, S. cerevisiae; sp, S. pombe; dm, D. melanogaster; ce,
Caenorhabditis elegans; AC17G8.13c (accession number Z69795), R07B5.8 (accession number Z72512), and C34B7.1 (accession number Z83220)
are open reading frames derived from various genome sequencing projects. C, amino acid sequence alignments of motif A among various members
of the GCN5-related N-acetyltransferase (GNAT) superfamily (53) (the Tip60 sequence is from Yamamoto and Horikoshi, see Ref. 55). Dark
shading indicates similar amino acids that are shared by more than six MYST domain proteins and more than three histone acetyltransferases,
whereas pale shading denotes similar amino acids that are shared by more than six MYST domain proteins but fewer than three histone
acetyltransferases. The underlined G residue is the mutated amino acid in the mof mutant defective in dosage compensation (50). D, Northern blots
were probed with a 32P-labeled 500-base pair fragment encoding the NH2-terminal portion of HBO1. The position of RNA size markers is also
shown. A probe of these blots with an actin probe revealed relatively constant RNA levels in these blots (data not shown).
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HMLa and genes placed near a telomere (48). In contrast,
Sas2p (and other SAS gene products) antagonizes silencing at
the HMRa locus when the essential HMR-E silencer element is
mutated. Interestingly, the latter function of Sas2p is mediated
through ORC (49).
Of the other MYST domain proteins, the Drosophila “males-
absent on the first” (mof) gene has been shown to be involved in
dosage compensation, a process that results in a two-fold in-
crease in transcription of the single X chromosome in male flies
and is accompanied by histone H4 hyperacetylation at lysine 16
(50). Interestingly, the mof mutant in which both dosage com-
pensation and H4 acetylation at position 16 are reduced has a
single amino acid substitution from Gly to Glu at position 691.
This glycine residue is absolutely conserved among the puta-
tive acetyl-CoA-binding motifs of the various MYST domain
family members and other histone acetyltransferases (Fig. 1C).
The human MOZ gene is rearranged and fused to the gene
encoding the CREB-binding protein in a recurrent chromo-
somal translocation characteristic of acute monocytic leukemia
(51). Tip60 interacts with the human immunodeficiency virus
Tat protein and augments expression from the HIV-1 promoter
(52).
Northern blot analysis revealed that the HBO1 mRNA was
expressed in all human tissues tested (Fig. 1D). HBO1 mRNA
abundance was not strictly correlated with cell proliferation
and was particularly high in ovarian tissue.
To test the interaction between hORC1 and HBO1 by an
independent approach, in vitro translated hORC1 and HBO1
proteins were subjected to co-immunoprecipitation assays. As
shown in Fig. 2A (left panel), polyclonal anti-hORC1 serum
co-immunoprecipitated the HBO1 polypeptide only in the pres-
ence of co-translated hORC1 (lanes 5-7). In a reciprocal exper-
iment, immunoprecipitation with polyclonal anti-HBO1 serum
(Fig. 2A, right) co-precipitated the hORC1 polypeptide only in
the presence of co-translated HBO1 protein (lanes 12–14). In
both cases, neither hORC1 nor HBO1 was immunoprecipitated
by pre-immune sera (lanes 2–4 and lanes 9–11). These results
confirm the existence of an interaction between hORC1 and
HBO1, although the possibility remained that protein(s) in the
rabbit reticulocyte lysate may mediate this interaction.
An association between HBO1 and hORC1 in human cells
was tested. Nuclear extracts from 293 cells were immunopre-
cipitated with polyclonal anti-hORC1 serum and co-precipita-
tion of the HBO1 polypeptide was assayed by Western blotting
analysis. The HBO1 polypeptide could be co-immunoprecipi-
tated only with immune anti-hORC1 serum (Fig. 2B, lanes 16
and 17), and co-immunoprecipitation was blocked by addition
of excess antigenic peptide (lane 18), but not by a nonspecific
peptide (lane 19). Because 20% of the nuclear extract used for
the immunoprecipitations was loaded in lane 15, we conclude
that only a small portion of the HBO1 protein associated with
hORC1 in human cells (Fig. 2B, left panel).
Although we could readily detect co-immunoprecipitation of
the HBO1 polypeptide with anti-hORC1 antibodies, the recip-
rocal experiment did not work even under mild washing con-
ditions. This was most likely due to epitope masking in the
HBO1-hORC1 complex or to the small portion of HBO1 bound
to hORC1, coupled with the fact that hORC1 exits as a rela-
tively low abundance protein in human cell extracts (data not
shown). To circumvent these problems, extracts from 293 cells
transiently expressing T7 epitope-tagged hORC1 were pre-
pared for immunoprecipitation with affinity purified anti-
HBO1 antibodies. This approach did reveal co-immunoprecipi-
tation of T7 epitope-tagged hORC1 (Fig. 2B, lane 23), that was
blocked by addition of excess antigenic peptide (lane 24), but
not by addition of a nonspecific peptide (lane 25). No HBO1
signal was detected in negative control reactions performed
either by immunoprecipitation from 293 cell extracts contain-
ing T7 epitope-tagged hORC1 with purified rabbit IgG (lane 21)
or by immunoprecipitation from mock-transfected 293 cell ex-
tracts with anti-HBO1 antibodies (lane 22).
We sought to determine whether HBO1 bound to the multi-
subunit ORC protein rather than to hORC1 alone. Unfortu-
nately, the only other human ORC subunit against which an-
tibodies were currently available is hORC2 (11). We have been
unable to co-immunoprecipitate hORC2 and HBO1 from hu-
man 293 cell nuclear extracts or from 293 cells overexpressing
the T7-hORC1 polypeptide (data not shown), although we know
FIG. 2. Association between hORC1 and HBO1 in the rabbit reticulocyte lysate and in human 293 cell extracts. A, hORC1 and HBO1
interaction in the rabbit reticulocyte lysate. hORC1 and HBO1 were translated in vitro in the rabbit reticulocyte lysate and immunoprecipitated
with either a rabbit anti-hORC1 serum (left panel) or a rabbit anti-HBO1 serum (right panel). hORC1 alone was expressed in lanes 2, 5, 9, and
12, whereas HBO1 alone was expressed in lanes 3, 6, 10, and 13. Both proteins were co-translated in lanes 4, 7, 11, and 14. One-tenth of the input
proteins was loaded in lanes 1 (hORC1) and 8 (HBO1) to give an estimate of the efficiency of immunoprecipitation. B, hORC1 and HBO1 interact
in human cell extracts. Left, following immunoprecipitation from 293 cell nuclear extracts with affinity-purified anti-hORC1 antibodies (CS171),
co-precipitated proteins were Western blotted and probed with anti-HBO1 antibodies. 293 cell nuclear extract (20% of input, lane 15), immuno-
precipitate using pre-immune serum (lane 16), immune serum (lane 17), immune serum plus antigenic peptide (lane 18), and immune serum plus
nonspecific peptide (lane 19). Right, 293 cells were electroporated with 10 mg of a plasmid for transient expression of T7 epitope-tagged hORC1.
Whole cell lysate from T7-ORC1-transfected 293 cells (lane 20), immunoprecipitate from transfected cells with purified rabbit IgG (lane 21),
immunoprecipitate from mock-transfected cells with anti-HBO1 antibodies (lane 22), immunoprecipitates from transfected cells with anti-HBO1
antibodies (lane 23), anti-HBO1 antibodies plus antigenic peptide L74–1 (lane 24), and anti-HBO1 antibodies plus nonspecific peptide (lane 25)
were subjected to Western blotting analysis and probed with a mouse monoclonal antibody against the T7 epitope tag.
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that the ectopically expressed T7-ORC1 did not efficiently as-
sociate with endogenous ORC2. In addition to the other ORC
subunits, the two ORC1-interacting proteins that have been
isolated play a role in heterochromatin function. The budding
yeast silencing protein Sir1p has been shown to bind to the
NH2-terminal portion (amino acid residues 5–228) of S. cerevi-
siae Orc1p (29). Similarly, Drosophila HP1 also binds to the
NH2-terminal domain of dORC1 (amino acid residues 161–319)
(35). Thus, the NH2-terminal domain of ORC1, although it is
not structurally conserved through evolution, may have a gen-
erally conserved function in recruitment of heterochromatin
proteins. To map the region of hORC1 responsible for binding
to HBO1, a series of hORC1 deletion mutants fused to the lexA
DNA-binding domain were constructed, co-transformed into
yeast L40 cells with a plasmid encoding HBO1 that was fused
to the GAL4 transcriptional activation domain, and the trans-
formants were tested for b-galactosidase activity (Fig. 3). Of six
ORC1 deletion mutants tested, only the mutant carrying amino
acid residues 210–861 of hORC1 was positive for b-galactosid-
ase activity. In the two-hybrid assay, the NH2-terminal portion
of hORC1 (1–208) was found to be dispensable for binding to
HBO1, consistent with the finding that anti-hORC1 antibodies
(CS171), which recognize an NH2-terminal peptide of hORC1,
did not disrupt the interaction between hORC1 and HBO1 in
the co-immunoprecipitation experiments using in vitro trans-
lated proteins (Fig. 2A).
Based upon the presence of a putative acetyl-CoA binding
motif shared by many acetyltransferases (Fig. 1C) and the
finding that the Drosophila mof mutant displays reduced
acetylation of histone H4 at lysine 16 on the male X chromo-
some (50), it has been proposed that MYST domain proteins
may generally act as HATs. Recently, both human Tip60 and
yeast Esa1p proteins were shown to be histone H3 and H4
acetyltransferases (54–56). To test whether HBO1 might have
HAT activity, the protein was immunoprecipitated from 293
cell nuclear extracts and assayed for HAT activity using recom-
binant core histones as substrates. Immunoprecipitates from
293 cell nuclear extracts with polyclonal anti-HBO1 antibodies
had an activity capable of acetylating histones H3 and H4 and,
more weakly, H2A (Fig. 4A, lane 4), suggesting that the im-
mune complex containing the HBO1 protein had HAT activity.
In contrast, pre-immune serum did not immunoprecipitate any
HAT activity (Fig. 4A, lane 3). In this experiment, human
HAT1, a histone H4 (and H2A) specific HAT was used as a
control (45).
To test whether any of these HAT activities were associated
with HBO1 in a salt-resistant manner, we immunoprecipitated
293 nuclear extract with anti-HBO1 antibodies and washed the
beads in buffers containing increasing concentrations of so-
dium chloride, followed by HAT assays. The H2A HAT activity
was eluted at relatively low salt concentration (less than 0.2 M
sodium chloride, Fig. 4B, lanes 7 and 8), suggesting that this
activity may be due to nonspecific adsorption of an H2A acetyl-
transferase to the HBO1 antibody beads. In contrast, most of
the H3 and H4 HAT activities remained bound to the HBO1
antibody beads up to at least 0.8 M sodium chloride (Fig. 4B,
lanes 10-12), suggesting that these activities were either due to
HBO1 itself or were mediated by polypeptides that were asso-
ciated with HBO1 in a highly salt-resistant manner. Under all
these conditions, the HBO1 polypeptide remained quantita-
tively bound to the antibody beads, as determined by Western
blotting (data not shown). To determine whether additional
polypeptides were associated with HBO1, HBO1 was eluted
from the immune complex by addition of excess antigenic pep-
tide. The eluted fraction was assayed for the presence of HBO1
by immunoblotting, HAT activity, and its polypeptide compo-
sition determined by SDS-polyacrylamide gel electrophoresis
and silver staining. The HBO1 polypeptide (Fig. 4B, lane 16)
and the histone H3 and H4 HAT activities (lane 19) were all
present in the eluate from the HBO1 antibody beads. Several
additional polypeptides co-eluted with HBO1 (Fig. 4B, lane 14).
This result suggests that either HBO1 itself or HBO1 and a
tightly associated protein acetylates H3 and H4.
To provide further support for the existence of a HBO1
protein complex, 293 cell nuclear extracts were fractionated by
anion exchange chromatography, and the column fractions
were directly probed by Western blotting with anti-HBO1 an-
tibodies or subjected to immunoprecipitation with anti-HBO1
antibodies, followed by HAT activity assays (Fig. 4D). This
fractionation procedure produced a peak of HBO1 protein (from
fractions 26 through 41) (Fig. 4D, upper panel). When immu-
noprecipitated with HBO1 antibodies, only the column frac-
tions coinciding with the peak of HBO1 polypeptide had HAT
activity (Fig. 4D, lower panel). The two peaks may represent
two separate complexes containing HBO1 or more likely, they
are due to the assay of HBO1 activity in immunoprecipitates.
Nevertheless, the HAT activity does co-fractionate with the
HBO1 protein. In addition, using cation exchange chromatog-
raphy on a POROS 20 HS column, a peak of HAT activity was
also observed to co-purify with HBO1 when fractions contain-
ing HBO1 were immunoprecipitated with HBO1 antibodies,
followed by HAT assays (data not shown). These co-fraction-
ation data strongly suggest that either HBO1 itself or a protein
tightly bound to HBO1 has HAT activity.
FIG. 3. Mapping of hORC1 region required for binding to HBO1. hORC1 deletion mutants fused to the lexA DNA-binding domain (lexA)
were individually co-transformed into yeast strain L40 along with a construct expressing the GAL4 transcriptional activation domain fused to the
ORC1-binding domain of HBO1 (amino acid residues 158–611). Transformants were grown in selective medium and b-galactosidase activity was
measured using both a quantitative liquid assay and a filter assay. The values shown are the mean 6 S.D. of three independent quantitative liquid
assays. ND, not detectable in the liquid assay. The gray box represents the cell division cycle-nucleoside triphosphate (CDC-NTP) region conserved
among the Oc1p- and Cdc6p-related proteins (11, 60).
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We also tried to determine whether HBO1 has an intrinsic
HAT activity by expressing recombinant HBO1 protein as a
GST fusion protein in E. coli. This protein had no detectable
HAT activity under a variety of pH (6.5–9.0) and divalent zinc
ion concentrations (1 mM-50 mM) (data not shown). (We rea-
soned that the HAT activity of MYST domain proteins may be
zinc-dependent because this domain commonly contains a
C2HC-type zinc finger.) One possibility is that HBO1 indeed
has intrinsic HAT activity but the recombinant protein ex-
pressed in E. coli either failed to fold into a proper three-
dimensional structure or lacked a post-translational modifica-
tion such as phosphorylation, resulting in a lack of HAT
activity. However, it is more likely that additional polypeptides
associated with HBO1 in human cells were required for HAT
activity. For instance, the HAT activity of S. cerevisiae and
human HAT1 are stimulated by association with a core his-
tone-binding subunit known as HAT2 and the transcriptional
activator GCN5 only acetylates nucleosomes efficiently when
the GCN5 catalytic subunit is part of a large multisubunit
complex (45, 57).
To test whether HBO1 alone or as part of a protein complex
was capable of acetylating nucleosomes, HAT activity was as-
sayed using reconstituted nuclear histones (H32zH42 tetram-
ers) as substrates. Human Hat1 holoenzyme used as a control
acetylated only free histones (Fig. 5, lane 6) but not nucleoso-
mal substrates (Fig. 5, lane 1) as previously reported (45). In
contrast, the protein complex containing HBO1 acetylated nu-
clear histones relatively weakly (Fig. 5, lane 2) compared with
free histones (lane 5). The histone acetyltransferase activity
using different substrates required different optimal assay con-
ditions, therefore there was a stronger signal using the free
histones (Fig. 5, lane 5) than with histones present in nucleo-
somes (Fig. 5, lane 2). The recombinant GST-HBO1 fusion
protein acetylated nuclear histones very weakly, and the la-
beled signal was only visible after longer exposure (Fig. 5, lane
4 and data not shown), whereas GST alone had no HAT activity
FIG. 4. Histone acetyltransferase
activity of the HBO1 complex. A pro-
tein complex that includes HBO1 has hi-
stone acetyltransferase activity when iso-
lated from human cells by immunoaffinity
purification. A, proteins from a 293 cell nu-
clear extract were immunoprecipitated with
either pre-immune serum (lane 3) or anti-
HBO1 serum (lane 4). Controls for HAT as-
says were performed without protein added
(lane 1) or with human HAT1 holoenzyme
(lane 2). B, HBO1 immunoprecipitated from
293 cell nuclear extract was washed with
buffers of increasing salt concentration, then
assayed for HAT activity. C, HBO1 immu-
noprecipitated from 293 cell nuclear extract
in 0.4 M NaCl with affinity purified anti-
HBO1 antibodies (CS446) cross-linked to
protein A-Sepharose was eluted by addition
of excess antigenic peptide. Eluates were
separated by SDS-polyacrylamide gel elec-
trophoresis followed by silver staining, as-
sayed for HBO1 protein by Western blotting
analysis, and also assayed for histone acetyl-
transferase activity. D, a 293 cell nuclear
extract was fractionated by anion exchange
chromatography. Fractions were probed
with anti-HBO1 antibody (top) and sub-
jected to immunoprecipitation with HBO1
antibodies followed by HAT assays (bottom).
L, column load; —, no protein control.
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(Fig. 5, lane 3) regardless of the exposure time. Thus HBO1 had
a very weak intrinsic HAT activity using the nucleosome his-
tones, but not free histones. Because HBO1 (pI 5 9.1) and
histones are both basic proteins, HBO1 protein may not readily
access free histone substrates in the HAT reaction due to mu-
tual electrostatic repulsion. On the other hand, when nucleo-
somal histones were used in the HAT assay, the positive charge
of histones was neutralized by deposition onto DNA, and this
may facilitate access by HBO1 protein, resulting in the weak
positive HAT activity. But it is clear that under the conditions
we tested, the native HBO1 protein complex had substantially
higher HAT activity than the recombinant GST-HBO1 protein.
Histone acetylation has been generally implicated in tran-
scriptional activation (58). Thus, one obvious possibility from
our studies is that HBO1 acetylation of histones or another
protein may activate DNA replication. This could facilitate
access to DNA replication initiation sites for DNA replication
proteins or plasticity of nucleosomes as DNA replication occurs.
Alternatively, because MYST domain proteins have been
shown to be involved in transcriptional silencing (Sas2p and
Sas3p) (48), dosage compensation (mof) (50), and transcrip-
tional activation (Tip60) (52), HBO1 may play a role in the
control of gene expression mediated by the interaction with
hORC1. We note that Drosophila ORC has been implicated in
position effect variegation of gene expression and heterochro-
matin function (35). It may be that ORC bound to heterochro-
matin could facilitate specific histone acetylation patterns,
thereby insuring the silencing of gene transcription in these
regions of the chromosomes.
In this regard, genetic studies with SAS2 in S. cerevisiae
suggest that this HBO1-related MYST domain protein antag-
onizes the function of ORC in DNA replication and effects
ORC-mediated transcriptional silencing of the mating-type
genes (49). Disruption of the SAS2 gene partially suppresses
the temperature sensitivity of orc2–1 and orc5–1 mutants.
Sas2p also antagonizes ORC mediated silencing at an altered
HMR silencer, but helps silencing at HML (49). Sas2p may
exert such functions by acetylation of histones, by acetylation
of one of the ORC subunits, or more simply, by binding to ORC.
It is not yet clear whether SAS proteins bind directly to Orc1p
in S. cerevisiae. None of the three budding yeast Sas2p-like
proteins (Sas2p, Sas3p, and Esa1p) that we tested bound to S.
cerevisiae Orc1p in two-hybrid assays (data not shown).
MYST domain proteins have been proposed to regulate tran-
scription through protein acetylation (48–51), although this
has not been shown directly for any member of this family.
Among the various members of the GCN5-related Ne-acetyl-
transferase superfamily, GCN5-related HATs, P/CAF, Hat1,
and GCN5 all contain three amino acid sequence motifs, named
A, B, and D (53). In contrast, MYST domain proteins only have
motif A. Because HBO1 protein is a MYST domain protein and
protein complexes containing the HBO1 exhibit histone acetyl-
transferase activity, we suggest that HBO1 is an acetyltrans-
ferase. Unlike Esa1p (54, 56), HBO1 seems to require other as
yet unidentified stimulatory subunits. Sequence comparisons
show that of the yeast MYST domain proteins, Esa1p is closest
in primary sequence to human HBO1, but we caution that
interpretation of functional homology based on sequence simi-
larity within a family of proteins is risky. For example, com-
parison of the primary sequences between the human and
yeast WD40-repeat, histone-binding proteins did not predict
functional homologues (45). In contrast, genetic interactions
between the genes encoding Sas2p and the ORC subunits sug-
gest that HBO1 might be functionally related to Sas2p protein.
Recently, Gu and Roeder (59) reported that p53 is acetylated
by p300, a known histone acetyltransferase and transcriptional
coactivator that is physically associated with p53. Acetylation
of p53 by p300 stimulated sequence-specific DNA binding by
p53 (59). Regulation of DNA binding by transcription factor
acetylation therefore represents a potentially novel mechanism
of transcriptional activation. By analogy, replication proteins
such as ORC may be regulated by HBO1-mediated acetylation.
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